Loading search results
PRISMA
PRISMA - A Pilot Randomized Phase II Trial on Social Prescriptions and Micro- Learning to Improve Care for Cancer Patients and Their Support Persons
Sponsor study identifier
Secondary identifiers
OTHER_GRANT · Nationales Centrum für Tumorerkrankungen (NCT)
interventional
384
1 country
8
Study Start
April 21, 2026
Actual (reported)Primary Completion
November 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
November 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Optimal patient-centered care is often not being delivered to cancer patients, especially to vulnerable populations like those living in underserved rural areas. This body of work will develop and pilot test a multicomponent intervention approach designed to improve the care and outcomes of cancer patients and their support persons (SPs) during and following their therapeutic journey. The intervention will involve the provision of social prescriptions and web-based micro-learning modules, as well as stepwise care based on ongoing monitoring of symptom burden and health. This project uses the strengths of innovative, individually tailored communication strategies and a comprehensive low-cost approach that are likely to support fair and equal patient access to optimal care beyond the funding period. By using a patient-driven approach in an interdisciplinary setting, it is anticipated that the intervention will improve the health outcomes of various patient populations, especially those living in rural areas. To achieve this, a methodologically robust mixed-methods approach and an effectiveness-implementation hybrid design will be employed to move effective strategies towards implementation into clinical practice. A number of standardized patient-reported outcome and experience measures will be used, including quality of life and knowledge of health and care. As a result of this research, an implementation toolbox will be developed that could be used by clinicians working in different healthcare settings and services, both nationally and internationally, to help provide highest quality cancer care.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 21, 2026
Actual (reported)August 19, 2026
Actual (reported)August 26, 2026
Actual (reported)November 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
November 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Functioning, 17 items (EORTC QLQ-F17)
Quality of life of patient and support person is obtained using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Functioning, 17 items (EORTC QLQ-F17). Scores range from 0 to 100, with higher scores indicating better functioning/quality of life.
From enrollment to the use of treatment at 4 weeks, 3 months, 6 months and 12 months
Cancer Behavior Inventory Brief Version (CBI-B-D-12)
From enrollment to the use of treatment at 4 weeks and 3,6 and 12 months
self-developed items on knowledge of health and care
From enrollment to the use of treatment at 4 weeks and 3,6 and 12 months
Healthcare Utilization (Care Level, Hospital Admissions, Length of Stay, Supportive Care Services)
From enrollment to the use of treatment at 4 weeks and 3, 6 and 12 months
A multicomponent intervention including social prescriptions, web-based micro-learning modules, and stepwise care based on symptom monitoring.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospital Augsburg
Augsburg, Bavaria, Germany
University Hospital Erlangen
Erlangen, Bavaria, Germany
First Submitted
August 19, 2026
First Posted
August 26, 2026
Study Start
April 21, 2026
Actual (reported)Primary Completion
November 30, 2028
EstimatedContact the study team to confirm eligibility.
University Hospital Regensburg
Regensburg, Bavaria, 93053, Germany
University Regensburg
Regensburg, Bavaria, 93053, Germany
University Hospital Würzburg
Würzburg, Bavaria, Germany
Faculty of Law, Business & Economics, Inst. for Healthcare Management & Health Sciences
Bayreuth, Germany
Charité - University Medicine Berlin
Berlin, Germany
University Hospital Köln
Cologne, Germany
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
November 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
August 26, 2026
Record last verified: 2026-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: